Core Viewpoint - Recent reports indicate that Aima Technology (603529) has undergone significant layoffs, particularly in its high-end brand "Lingji" and international business departments, with claims of over 50% staff reduction, although the company denies these allegations and describes the changes as normal personnel adjustments [1][2] Group 1: Layoff Reports - Aima Technology reportedly experienced layoffs exceeding 50%, with the "Lingji" brand and international business departments being the most affected [1] - Employees in other departments, including after-sales, also faced varying degrees of departures, marking this as the largest personnel adjustment in recent years [1] - Aima Technology's investor relations department refuted the claims, stating that the departments are operating normally and that the reported layoffs are exaggerated and misleading [1] Group 2: Company Performance - According to Aima Technology's Q3 2025 report, the company achieved revenue of 21.092 billion yuan, a year-on-year increase of 20.78%, and a net profit of 1.907 billion yuan, up 22.78% year-on-year [1] - As of the end of 2024, Aima Technology's parent company employed 1,382 people, while its main subsidiaries had 7,546 employees, totaling 8,928 employees, which is a 5.78% decrease compared to 2023 [1] Group 3: Strategic Developments - Aima Technology announced the launch of its high-end sub-brand "Lingji" as a strategic supplement to its market positioning, aiming for differentiated development in brand positioning, product design, and channel systems [2] - The company plans to enhance its product investment and upgrades in the mass premium market following the implementation of new national standards [2] - Aima Technology's international business department, led by the current vice president, aims to expand its international market presence while optimizing supply chains and production layouts, focusing on local operations in markets like Indonesia and Vietnam [2]

Core Viewpoint - The company aims to enhance performance and ensure long-term shareholder returns by improving business quality and efficiency in response to short-term revenue pressures in the cosmetics and pharmaceutical sectors [1]. Group 1: Cosmetics Sector - The cosmetics segment will focus on differentiated brand development, leveraging the growth momentum of the Yilian spray product line while strengthening its advantages through brand culture promotion and targeted marketing [1]. - The company plans to accelerate the adjustment of the Aier Doctor brand, optimizing product lines by launching the upgraded 287 product line and an anti-aging series, alongside implementing comprehensive price control and content innovation to drive traffic conversion [1]. - New brands like Kemi will be rapidly scaled up to fill the growth gap [1]. Group 2: Pharmaceutical Sector - The pharmaceutical segment is seizing opportunities in the food and drug integration market, accelerating market penetration of seven new products based on industry standards it has led in formulating [1]. - The company is increasing its investment in research and development to promote both short-term performance improvement and long-term sustainable growth [1].